Muraro, Paolo A.
Martin, Roland
Mancardi, Giovanni Luigi
Nicholas, Richard
Sormani, Maria Pia
Saccardi, Riccardo
Article History
First Online: 16 June 2017
Competing interests
: P.A.M. declares honoraria for speaking and travel support from Bayer, Biogen, Merck Serono and Novartis. G.L.M. has received support from Biogen (honoraria for lecturing, travel expenses for attending meetings and financial support for research), Genzyme (honorarium for lecturing), Merck Serono, Novartis, Teva (financial support for research) and Sanofi (honorarium for speaking). R.N. declares compensation and support from Biogen (principal investigator, funds for staff, research, organizing education, honorarium for speaking, advisory boards), Genzyme (honorarium for speaking, advisory boards, organizing education), NICE diagnostics advisory committee, Expert NICE Alemtuzumab committee; Novartis (principal investigator, honorarium for speaking, advisory boards), Roche (advisory boards). M.P.S. has received personal compensation for consulting services and for speaking activities from Biogen, Genzyme, Merck Serono, Novartis, Roche and Teva. R.S. has received honoraria for lecturing from Sanofi.